image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

Creo

October 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CREO
  • Price:
  • 31.5p
Creo’s H1 delivered 15% growth in sales to £15.7m. H1 numbers are small as commercialisation of Creo’s core Speedboat technology is just starting to accelerate, generating £0.9m (H122: £0.5m), whilst  Kamaptive-related income was £0.5m (H122: £0.9m) and Endotherapy consumables delivered £14.3m (H1/22: £12.8m). Underlying administrative expenses continued to fall (£17.9m from £19.6m) resulting in a lower underlying EBITDA loss of £9.2m. Net cash was £26.5m. There were 115 trained Speedboat users at the end of H1, up 44% from 80 at the end of FY22, driving an increase in procedures. Training capacity had been a key bottleneck for growing the pool of users but Creo says the number of clinician trainers is up 65% since December. A Cap ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Creo (July 2023)
Creo (May 2023)
Creo Medical - Very interesting special situation (March 2023)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW